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Abstract
Background: Children aged under five years with severe acute malnutrition (SAM) in Africa and
Asia have high mortality rates without effective treatment. Primary care-based treatment of SAM
can have good outcomes but its cost effectiveness is largely unknown.
Method: This study estimated the cost effectiveness of community-based therapeutic care (CTC)
for children with severe acute malnutrition in government primary health care centres in Lusaka,
Zambia, compared to no care. A decision tree model compared the costs (in year 2008
international dollars) and outcomes of CTC to a hypothetical 'do-nothing' alternative. The primary
outcomes were mortality within one year, and disability adjusted life years (DALYs) after surviving
one year. Outcomes and health service costs of CTC were obtained from the CTC programme,
local health services and World Health Organization (WHO) estimates of unit costs. Outcomes of
doing nothing were estimated from published African cohort studies. Probabilistic and
deterministic sensitivity analyses were done.
Results: The mean cost of CTC per child was $203 (95% confidence interval (CI) $139–$274), of
which ready to use therapeutic food (RUTF) cost 36%, health centre visits cost 13%, hospital
admissions cost 17% and technical support while establishing the programme cost 34%. Expected
death rates within one year of presentation were 9.2% with CTC and 20.8% with no treatment
(risk difference 11.5% (95% CI 0.4–23.0%). CTC cost $1760 (95% CI $592–$10142) per life saved
and $ 53 (95% CI $18–$306) per DALY gained. CTC was at least 80% likely to be cost effective if
society was willing to pay at least $88 per DALY gained. Analyses were most sensitive to
assumptions about mortality rates with no treatment, weeks of CTC per child and costs of
purchasing RUTF.
Conclusion: CTC is relatively cost effective compared to other priority health care interventions
in developing countries, for a wide range of assumptions.
Background
Children aged under five years with severe acute malnutri-
tion (SAM) in Africa have high mortality rates without
effective treatment [1-5]. Hospital inpatient treatment of
SAM can reduce mortality [5], but in developing countries
hospital treatment is too inaccessible and costly for most
children with SAM. Community-based therapeutic care
(CTC) is a recent model for early diagnosis and treatment
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of SAM in ambulatory primary health care settings. The
key nutritional component of SAM treatment is ready to
use therapeutic food (RUTF). This is a nutrient-dense food
with a nutrient content/100 kcal that is similar to F100
milk, the diet recommended by the World Health Organ-
ization (WHO) in the recovery phase of the SAM treat-
ment [6]. A major advantage of RUTF over F100 is that it
contains little water and is thus resistant to microbial con-
tamination, and suitable for storage and use at home
without refrigeration [7]. Other key components of CTC
are simplified clinical protocols, decentralised provision,
community mobilisation and high population coverage
[8]. CTC also includes supplementary feeding for moder-
ate malnutrition, which is not considered in this study [8]
Several home-based RUTF programmes in developing
countries have shown good outcomes [8-10]. However
there have been few controlled trials comparing mortality
rates with other treatments [11,12]. No trials have pro-
spectively compared CTC with no treatment, which would
be unethical. Although resources constraints are critical
for the expansion of CTC, we are aware of only one pub-
lished study reporting original data on costs of ambula-
tory treatment of severe acute malnutrition in a
developing country [13]. That trial, with 437 children in
Bangladesh in 1990 and 1991, showed that inpatient care
cost $156 per child, day care cost $59 and domiciliary care
cost $29.
Lusaka, Zambia, provides an innovative example of large
scale provision of CTC through government primary
health care centres. Since 2005 the Lusaka District Health
Management Team (LDHMT), which is responsible for
the city's 25 primary health care centres, has steadily
expanded CTC provision by its staff working in these
health centres. By January 2008, 21 of the 25 LDHMT
health centres were providing CTC. CTC clinics were set
up within each health centre, each staffed by a nurse, a
health educator and two volunteers. Nurses were trained
to diagnose SAM in children under 5 years of age, by
measuring mid upper arm circumference (MUAC) and
examining children for bilateral pedal pitting oedema.
SAM was defined as MUAC of 11 cm or less, or bilateral
pitting oedema [8]. Children were treated with RUTF of
200 kcal/Kg/day, broad-spectrum antibiotics, vitamin A,
folic acid, anti-helminthics and, if indicated, anti-malarial
treatment [8]. They were then asked to return weekly until
they had recovered. Recovery was defined as having
MUAC > 11 cm, weight gain and no oedema for at least
two weeks, and clinically well [8]. Children with initial
MUAC of 11 cm or less at admission were supposed to
receive at least 8 weeks treatment, although in practice
duration of treatment varied. Children were referred to
hospital for inpatient care if they failed to respond to
treatment, deteriorated or were severely ill and required
hospital care.
Twenty volunteers attached to each health centre screened
children at the health centres and in the community and
referred those with SAM to CTC. Government and private
sector nurses and traditional health practitioners working
near to each health centre were trained and encouraged to
identify and refer SAM cases. Popular art theatre discus-
sions were held to raise community awareness of SAM and
CTC. Valid International, a company specialising in nutri-
tional research in developing countries, helped initiate the
programme and provided technical support to the
LDHMT for implementation and staff training. RUTF was
manufactured in Lusaka or imported, and delivered to
LDHMT medical stores free of charge.
The aims of this study were 1) to describe the outcomes of
CTC in Lusaka, 2) to estimate the costs of CTC and 3) to
estimate the effectiveness and cost effectiveness of this
type of CTC, compared to no treatment. The reasons for
comparing CTC to no treatment were, first, to enable the
cost-effectiveness of CTC to be compared to any other
health care intervention and, second, because comparable
data on costs of alternative ways of treating SAM in this
population were not available.
Methods
The study was a cost effectiveness analysis based on a deci-
sion tree model [14]. Cost and cost effectiveness were con-
sidered from the perspective of health services. The
existing model of care was compared to a hypothetical
alternative of providing no treatment [15]. Household
and societal costs of illness and care were beyond the
scope of this study.
Decision tree
The structure of the decision tree is shown in Figure 1. The
square represents choice, circles represent chance (proba-
bilities) and triangles represent outcomes. There are two
options: "do nothing" or "CTC". For each option, various
things could happen to each child, leading ultimately to
recovery or death. For the "do nothing" option, death
rates differed according to whether children were HIV
infected or not. For the "CTC" option, HIV status was not
considered, because the effects of HIV/AIDS were already
incorporated into known CTC outcomes, and because the
HIV status of most children receiving CTC was not known.
Children receiving CTC in health centres could have one
of the 4 outcomes known to the CTC programme. Chil-
dren referred to hospital, and children who defaulted,
then either died or recovered. For each option, the proba-
bility of each outcome was entered into the model to cal-
culate expected rates of death or recovery. For the CTC
option, costs of CTC and of hospital treatment were alsoCost Effectiveness and Resource Allocation 2009, 7:2 http://www.resource-allocation.com/content/7/1/2
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entered into the model. The "do nothing" option was
assumed to cost health services nothing. Effectiveness of
CTC was calculated as the difference in death rates
between the two options. The cost of CTC, divided by the
effectiveness of CTC, is the incremental cost effectiveness
ratio, expressed in dollars per life saved. Assuming that
each child who recovers has a life expectancy of 33.3 dis-
ability adjusted life years [5], cost effectiveness was also
expressed in dollars per DALY gained.
Model parameters: probabilities of outcomes
Model parameters are shown in Table 1. The primary out-
comes of interest were mortality up to year after develop-
ing SAM, and expected DALYs after surviving one year.
For the 'do nothing' option, expected mortality was based
on evidence from a review of child mortality rates associ-
ated with malnutrition in developing countries [1]. In par-
ticular we based mortality rates on rigorous community
based cohort studies conducted in Malawi [1,2] and
Uganda [3,4] in the late 1980s that used MUAC as a pre-
dictor of mortality. In the Lusaka CTC population, the
median MUAC in children with MUACs of 11 cm or less
was 10.6 (interquartile range 10.0–10.8) cm and in chil-
dren with oedema the median was 12.0 (interquartile
range 11.2–13.0) cm. Mortality rates with bilateral pedal
oedema were assumed to be the same as with MUAC of 11
cm or less, as we found in this CTC programme. At the
time of the cohort studies [1-4], for such children mini-
mal treatment was available and the prevalence of HIV
Decision tree Figure 1
Decision tree.
Table 1: Assumptions, distributions and sources of model parameters
Parameter Mean Standard error* Source and comments
Outcomes
Do nothing option
Mortality without CTC (HIV-) 0.18 0.045 [1-4] SE assumed.
Relative risk of death with HIV, no CTC 2.0 0.5 [18] SE assumed
Prevalence of HIV in under fives 0.15 0.0375 [16,17] SE assumed.
CTC option
Death rate during CTC 0.026 0.0032 Programme data.
Proportion defaulting from CTC 0.172 0.0075 Programme data.
Death rate in defaulters from CTC 0.058 0.029 Assumed. SE set so 95% CI is +/- 100% of mean
Hospital referral rate from CTC 0.059 0.0047 Programme data.
Death rate in hospital 0.37 0.093 UTH data. SE assumed
Mortality within a year of recovery 0.0364 0.0091 [19]
Expected DALYs if child recovers 33.3 NA [5]
Costs (CTC option only)
No. weeks of CTC – recovered 6.6 1.6 Programme data.
No. weeks of CTC – referred 4.8 1.1 Programme data.
No. weeks of CTC – died 3.6 1.6 Programme data.
No. weeks of CTC – defaulted 5.1 1.5 Programme data.
Cost per health centre visit $4.24 $1.06 LDMHT. SE assumed.
Cost per kg of RUTF $6.10 $1.53 Valid International. SE assumed.
Kg of RUTF per week per child 1.90 0.016 Programme data.
Cost of community mobilisation per child $1.06 $0.27 LDMHT. SE assumed
Valid cost per child $68.69 $17.17 Valid International. SE assumed.
Cost per day in hospital $41.35 $10.34 [24] SE assumed.
Days in hospital 14 3.5 UTH data. SE assumed.
* SE standard errors for probabilistic sensitivity analysis; normal distributions assumed.
CI confidence interval. $ international dollars, year 2008. NA not applicable. UTH Lusaka University Teaching HospitalCost Effectiveness and Resource Allocation 2009, 7:2 http://www.resource-allocation.com/content/7/1/2
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was negligible. Non-CTC children were therefore stratified
by HIV status, to account for the increased death rate with
HIV, the prevalence of which has increased over the past
20 years. The HIV prevalence estimates was based on
numbers of infected children in Zambia, from UNAIDS
[16] and numbers of children aged under 5 from the Zam-
bia census [17]. Mortality with HIV was assumed to be
double that without HIV [18].
For the CTC option, outcomes at the end of health centre
care were death, recovery, referral to hospital, or default
(Table 1). These outcomes were known from programme
data for 2523 patients treated from September 2005 to
September 2007. Among children referred from CTC to
hospital, the death rate was assumed to be 37%, which
was the death rate in the University Teaching Hospital
(UHT) acute malnutrition ward (personal communica-
tion Dr B Amadi, UHT paediatrician). The death rate
among children who defaulted from CTC was assumed to
be the same as for all other children, including those
referred to hospital, because they had similar prognostic
characteristics. That is, among children who defaulted,
mean initial MUAC was 11.2 cm and 25.2% had oedema;
among children who did not default, mean initial MUAC
was 11.4 cm and 25.3% had oedema. The cohort esti-
mates of mortality used for the "do nothing" option were
based on one year of follow up, but CTC programme data
were based on an average of 7 weeks of follow-up. To be
able to compare annual mortality rates between the two
options we therefore assumed that CTC patients who did
not die during CTC or in hospital had the same annual
mortality rate as all children aged under 5 in Zambia. The
under five mortality rate in Zambia in 2006 was 182 per
thousand live births [19]. Therefore we assumed that
3.64% (0.182/5) of children who recovered during CTC
would die within a year.
Model parameters: cost of CTC and hospital care
All costs were expressed in international dollars for the
year 2008. Unit costs measured in Zambian kwacha and
UK pounds were deflated to their year 2000 equivalents
[20,21], then converted to year 2000 international dollars
using WHO exchange rates to reflect purchasing power
parity [22]. They were then adjusted to year 2008 values
using United States inflation rates from 2000 to 2008
[23].
The relevant types of cost were for health centre visits,
RUTF, hospital admissions and Valid International's con-
tribution to establishing the programme. Costs per health
centre visit were based on the 2008 LDHMT budget,
minus the proportion of the LDHMT budget devoted to
non-health centre services (and the proportional adminis-
tration costs), plus LDHMT staff salaries paid by the pro-
vincial health department. This total annual cost of health
centre care was then divided by the number of health cen-
tre visits during 2007 to produce an average cost per
health centre visit. The cost of community mobilisation
was estimated from the 2008 LDHMT budget for commu-
nity based child health activities, 10% of which was
assumed to be for CTC (personal communication, Dr C
Mbwili, LDHMT). This was multiplied by 2.4 years of the
CTC programme and divided by the 3358 children
treated, producing a mean cost of community mobilisa-
tion per child. The cost per kilogram of RUTF in Zambia
was estimated by Valid International. Programme data
showed that the mean body weight per child was 7.4
(standard error 0.065) Kg, and that each child received
200 kcal/Kg/day, which is equivalent to 1.9 (standard
error 0.016) Kg RUTF per week. Costs of ambulatory CTC
were health centre unit costs plus RUTF costs, multiplied
by the duration of treatment. Treatment duration was
stratified by CTC outcome (Table 1).
Valid International expenditure on the Zambia pro-
gramme was reported from April 2005 to January 2008.
This excluded RUTF production (which was already
accounted for), and included administration, training,
research, local and international travel, and consultancy.
For each line item of expenditure, the proportion attribut-
able to CTC was estimated by two senior Valid Interna-
tional personnel. This was divided by the number of
children who received CTC over the same period, to pro-
duce an average cost to Valid International per child,
regardless of duration of treatment.
Costs per day of hospital inpatient care at the Lusaka Uni-
versity Teaching Hospital were not available and so were
based on WHO estimates of tertiary hospital care in Zam-
bia, adjusted to include drug costs [24]. For children
referred to hospital, these daily costs were multiplied by
the average length of stay in the Lusaka University Teach-
ing Hospital acute admission ward (personal communica-
tion, Dr B Amadi).
Analysis
The cost effectiveness analysis was carried out with Tree
Age Pro Healthcare software and checked with Microsoft
Excel. Point estimates were calculated for costs, outcomes,
CTC effect (that is, difference in mortality) and incremen-
tal cost effectiveness ratios (CTC costs divided by CTC
effect), using the point estimates for each model parame-
ter.
Probabilistic sensitivity analyses [14,25] were conducted
with Tree Age Pro Healthcare, to quantify the combined
uncertainty about costs, effects, and cost effectiveness,
based on the uncertainty about all of the model's param-
eters. First, the distribution of each parameter was defined
(Table 1). Parameter standard errors were assumed toCost Effectiveness and Resource Allocation 2009, 7:2 http://www.resource-allocation.com/content/7/1/2
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have normal distributions and were estimated from pro-
gramme data where available. If not available, to be con-
sistent standard errors were defined as 25% of the mean,
so that 95% confidence intervals would be 50% more or
less than the mean; the only exception was for mortality
among defaulters, for which the standard error was larger
to reflect greater uncertainty. Monte Carlo simulation was
performed, with 10000 iterations per analysis. From sim-
ulation results we estimated 95% confidence intervals for
each output of the model from their percentiles. We also
calculated the probability that the intervention was cost
effective for a range of values that society might be willing
to pay to obtain one unit of effect (that is, dollars per life
saved or per DALY gained).
Finally, one- and two-way sensitivity analyses were con-
ducted. One way sensitivity analyses were calculated using
the mean values of each parameter, and varying the values
of one parameter at a time. Two way sensitivity analyses
were conducted to examine the effects of simultaneously
varying the values of two parameters.
Patient's consent and research ethics committee approval
were not necessary because the study was based on aggre-
gate programme data and published literature and did not
require access to individual patient records.
Results
CTC cost an average of $203 per child, 70% of which was
due to RUTF and Valid International's costs (Tables 2 and
3). Health centre visits and hospital admissions
accounted for 30% of the CTC costs. Of Valid Interna-
tional's costs, 51% were for personnel, 42% were for travel
and subsistence, and 7% were for other items.
The results of the Monte Carlo simulation, from which
confidence intervals and probabilities of cost effectiveness
were estimate, are shown in Figure 2. Each dot represents
the cost and effect of CTC for each iteration. The expected
mortality rates after one year were 9.2% with CTC and
20.7% with no treatment – a risk difference of 11.5%
(Table 3). Thus one life would be saved for every 8.7 chil-
dren who received CTC. The average increase in expected
DALYs with CTC was 3.8 per child. The relative risk of
death with CTC compared to doing nothing was 0.44
(95% CI 0.26–0.95).
The cost of CTC was $1760 (95% CI $592–$10142) per
life saved and $ 53 (95% CI $18–$306) per DALY gained.
CTC was more likely than not to be cost effective if society
was willing to pay at least $1700 per life year gained (Fig-
ure 3). CTC was more than 80% likely to be cost effective
if society was willing to pay at least $3000 per life saved.
With regard to DALYs, CTC was more likely than not to be
cost effective if society was willing to pay at least $52 per
DALY gained (Figure 4). CTC was more than 80% likely to
be cost effective if society was willing to pay at least $88
per DALY gained.
The model was most sensitive to assumptions about
expected mortality without treatment, weeks of CTC per
child, effect of HIV on mortality without CTC, hospital
referral rate, cost per kilogram of RUTF, quantity of RUTF
consumed per week and technical support costs (Table 4).
Cost effectiveness estimates were less sensitive to assumed
unit costs of health centre visits and hospital admissions.
The CTC outcome parameter which was least well known
– death rates among defaulters – had relatively little influ-
ence on cost effectiveness estimates. The model's sensitiv-
ity to combinations of the most influential variables is
shown in Figures 5 and 6. They show that the cost per life
saved increased exponentially as the assumed death rate
without treatment decreased towards 12%, and increased
linearly with increasing weeks of CTC per child and cost
per kilogram of RUTF.
Table 2: Mean costs of community-based therapeutic care per child
Cost item Unit cost ($) Mean number of items per child Mean cost per child ($) % of total
RUTF (Kg) 6.20 11.70 72.52 35.8
Technical support 68.69 1.00 68.69 33.9
Hospital per day 41.35 0.83 34.16 16.9
Health centre visits 4.24 6.16 26.10 12.9
Community mobilisation 0.66 1.0 1.06 0.5
Total 202.53 100.0
RUTF ready to use therapeutic foodCost Effectiveness and Resource Allocation 2009, 7:2 http://www.resource-allocation.com/content/7/1/2
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Discussion
The study shows that CTC for SAM among children aged
under five years in Lusaka results in good outcomes at a
reasonable cost. The estimated cost of $1760 per life
saved, or $53 per DALY gained, suggests that this model
of CTC has a similar cost effectiveness to other priority
child health interventions in Africa such as immunisation,
micronutrient supplementation, and treatment of pneu-
monia and diarrhoea [26]. The cost per DALY gained was
very similar to the result of a World Bank study based in
Guinea in 1998 [27], despite the different methods of
evaluation. WHO has classified child health interventions
as highly cost effective if the cost per DALY gained is less
than the country's gross national product per capita
[15,26]. This can be used as one indicator of society's will-
ingness (or at least ability) to pay for improved health.
This supports CTC, since Zambia's gross national income
per person per year was $1000 in 2006 [28].
The main strengths of this study are that 1) it was based
on an innovative large scale programme implemented
through government primary care health centres through-
out a Zambian city, 2) it had original and up to date pro-
gramme data on costs, outcomes and severity of SAM and
3) it compared the costs and outcomes of the programme
with what would be expected without any intervention.
Comparison with no treatment allows the cost effective-
ness of this model of CTC to be compared with any other
intervention in health, and not just to be considered as an
incremental change to alternative nutrition strategies
[15,29]. This method of comparing a health care interven-
tion with the hypothetical alternative of doing nothing,
and using probabilistic sensitivity analyses, follows WHO
health economists' recommendations for economic eval-
uation and priority setting [15,30].
The main limitation of comparing CTC to doing nothing
is that it is dependent on assumptions about the out-
comes and costs of no health care for SAM. We do not
know what these children's mortality rates would have
been without treatment. Most recent studies of mortality
among children with SAM have been among children
who received treatment [5,9,10]. We therefore relied on
Table 3: Costs and effects of community-based therapeutic care compared to no treatment
CTC No treatment Difference
Mean (95% CI) Mean (95% CI) Mean (95% CI)
Mean cost per patient ($) 203 (139–274) 0 0 203 (139–274)
Death rate (%) 9.2 (4.3–7.25) 20.8 (10.5–31.8) 11.5 (0.4–23.0)
Expected DALYs* 30.2 (29.3–31.2) 26.4 (22.7–29.8) 3.8 (0.14–7.7)
CTC community-based therapeutic care.
* assuming 33.3 disability adjusted life years (DALYs) expected after surviving one year [5]
Incremental costs and effects from Monte Carlo simulation Figure 2
Incremental costs and effects from Monte Carlo sim-
ulation.
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Probability CTC was cost effective for different amounts will- ing to pay per life saved Figure 3
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population based cohort studies in Africa carried out
about 20 years ago when little health and nutritional care
was available [1-4]. However, we have accounted for the
likely effect of the HIV epidemic, and UNICEF estimates
indicate that under five mortality rates in Zambia
remained constant between 1990 and 2006 [31].
Although comparable mortality rates were not available
for children with oedema, this programme's data showed
that mortality among children with oedema was the same
as for children with MUAC of 11 cm or less and with no
oedema. Our assumption of 18% mortality without treat-
ment does not seem excessive considering that, in 9 ran-
domised trials of hospital treatment of SAM, short term
mortality rates ranged from 16% – 46% (median 20%)
among control group children who received conventional
treatment [5]. Recent African hospital case series have also
shown higher short term mortality rates for children with
MUAC < 11.5 cm, despite treatment [18,32,33]. Further-
more, UNICEF estimates [31] show that under five mor-
tality rates in Zambia were higher than in Malawi and
Uganda where the cohort studies were conducted. Even if
we assumed that mortality rates without treatment were as
low as 12%, CTC was still relatively cost effective, with a
cost per life saved of about $5000 (Figure 5), and with a
cost per DALY gained of $150.
The deterministic sensitivity analyses (Table 4) showed
that results were most sensitive to assumptions about
mortality without treatment (discussed above), costs of
RUTF, and costs of technical support, which has implica-
tions for future research priorities. The importance of
mortality without CTC highlights the need for future stud-
ies to track mortality in comparator populations. RUTF
accounted for 36% of total CTC costs, underlining the
desirability of reducing RUTF costs in future. It seems
likely that an alternative less costly RUTF formulation,
using locally grown soya, sorghum and maize instead of
imported milk powder and peanuts, could be as effective
at lower cost. Larger scale production and food procure-
ment would also be likely to reduce costs in future. This
alternative will be evaluated in a randomised trial and
economic evaluation soon to be started in this setting. The
relatively high cost per child of Valid International's input
was largely due to technical support while setting up the
programme. At least some of these costs could thus have
been considered as capital costs and spread over a longer
period, as the programme becomes increasingly run by
government health services. In future Valid International's
emphasis will change from ongoing technical support to
training health ministry trainers, which could be less
costly. Thus costing of longer term and larger scale imple-
mentation will be needed in future.
Probability CTC was cost effective for different amounts will- ing to pay per DALY gained Figure 4
Probability CTC was cost effective for different 
amounts willing to pay per DALY gained.
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Cost per life saved for different assumptions about death  rates without treatment and number of weeks of CTC per  child Figure 5
Cost per life saved for different assumptions about 
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of CTC per child.
0
1000
2000
3000
4000
5000
6000
456789 1 0
Mean weeks of CTC
$
 
p
e
r
 
l
i
f
e
 
s
a
v
e
d
0.12
0.14
0.16
0.18
0.2
0.22
0.24
0.26
0.28
0.3
Death rate 
without 
treatment
Cost per life saved for different assumptions about death  rates without treatment and costs per kilogram of RUTF Figure 6
Cost per life saved for different assumptions about 
death rates without treatment and costs per kilo-
gram of RUTF.
0
1000
2000
3000
4000
5000
6000
123456789 1 0
Cost of RUTF ($ per Kg)
$
 
p
e
r
 
l
i
f
e
 
s
a
v
e
d
0.12
0.14
0.16
0.18
0.2
0.22
0.24
0.26
0.28
0.3
Death rate 
without 
treatmentCost Effectiveness and Resource Allocation 2009, 7:2 http://www.resource-allocation.com/content/7/1/2
Page 8 of 9
(page number not for citation purposes)
Several other limitations and assumptions of the study
should be considered. First, it would have been desirable
also to have compared CTC with alternative ways of treat-
ing SAM. As stated in the Background, although other
studies have compared outcomes of community- and hos-
pital-based treatment of SAM [11,12], only one study
compared costs [13]. If community based care was at least
as effective as hospital-based care [13], it is plausible that
the former would be less costly and thus more cost effec-
tive. However we could not make such a comparison with
local data because our examination of clinic records
found that comparable outcome measures prior to CTC
were not available. Second, unit costs of hospital and
health centre care were not available specifically for chil-
dren with SAM. However neither of these unit costs had
much influence on overall cost and cost effectiveness esti-
mates (Table 4). Third, the mortality rate among children
who defaulted was unknown but this too had relatively
little influence. Fourth, HIV prevalence among this popu-
lation was not known. If HIV prevalence was higher than
the 15% assumed, that would increase the estimated cost
effectiveness of CTC by increasing the mortality rate with-
out CTC. Fifth, DALY estimates assumed that health and
life expectancy would return to normal after recovery,
although it is plausible that children who recovered
would be at higher risk of stunting and poorer health in
future [5]. Alternatively, they could be relatively hardy
survivors. However, it is easy for readers to adjust these
effectiveness and cost effectiveness estimates to reflect dif-
ferent assumptions about expected DALYs after recovery.
For example, if one assumed that 25 DALYs were expected
after recovery, instead of 33.3, the cost per DALY gained
would be $53 × 33.3/25 = $71. Finally, discounting was
not used because child level costs covered less a year and
expected DALYS were assumed to be net present values.
Conclusion
The Lusaka model of CTC for SAM appears highly cost effec-
tive. This study suggests that this form of CTC should be
expanded to the rest of Zambia and adapted for other African
countries with high rates of SAM. Cost effectiveness could be
increased in future with less external technical support, as
CTC is increasingly implemented through government serv-
ices, and by reducing RUTF costs through local and larger
scale production and sourcing of components. Priorities for
future research include controlled trials and economic evalu-
ations of alternative ways of providing CTC, such as hospital-
based care or selective SAM-only programmes. This requires
prospective collection of individual level data on severity of
SAM, HIV status, use of health services and outcomes, and
active follow up of children who default.
Abbreviations
CTC: community-based therapeutic care; LDHMT: Lusaka
District Health Management Team; MUAC: mid upper
arm circumference; RUTF: ready to use therapeutic food;
SAM: severe acute malnutrition; UNICEF: United Nations
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Table 4: Sensitivity analysis: cost per life saved for different values of model parameters
Parameter values Incremental cost effectiveness ratio ($ per life saved)
Base Minus 50% Plus 50% Low High Range
Outcome probabilities
Death rate within a year without CTC HIV- * 0.18 0.09** 0.27 17502** 927 16576
Relative risk of death if HIV+, no CTC * 2 1 3 2300 1426 874
Refer to hospital from CTC 0.059 0.030 0.089 1479 2100 622
Death within a year if recover with CTC 0.0364 0.0182 0.0546 1520 2091 571
HIV prevalence* 0.15 0.075 0.225 1994 1575 419
Death during CTC 0.026 0.013 0.039 1586 1978 392
Death rate in hospital 0.37 0.185 0.555 1608 1944 337
Death rate among defaulters 0.045 0.022 0.067 1703 1821 118
Default from CTC 0.173 0.087 0.260 1721 1802 82
Costs
Weeks of CTC – Recovered 6.6 3.3 9.9 1419 2101 682
RUTF per Kg ($) 6.20 3.10 9.30 1445 2075 630
Mean Kg of RUTF per child per week 1.90 0.95 2.85 1445 2075 630
Valid cost per child ($) 68.69 34 103 1462 2058 597
Hospital cost per day ($) 41.35 20.68 62.03 1612 1908 297
Days in hospital 14 7 21 1612 1908 297
Costs per health centre visit ($) 4.24 2.12 6.36 1647 1873 227
Weeks of CTC – Defaulted 5.1 2.6 7.7 1699 1821 123
Weeks of CTC – Referred 4.8 2.4 7.2 1740 1780 39
Weeks of CTC – Died 3.6 1.8 5.4 1754 1767 13
Community mobilisation per child $ 1.06 0.5 1.6 1755 1765 9
* CTC is more cost effective if these parameters are greater.
** note higher mortality with CTC than with no careCost Effectiveness and Resource Allocation 2009, 7:2 http://www.resource-allocation.com/content/7/1/2
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